(NMK-Studio / Sjutterstock.com)
Staying healthy through proactive self-care is crucial, and a key component is understanding and managing often-silent health risks. Simple blood tests can reveal a lot, including potential heart disease.
For individuals who don’t respond sufficiently to standard cholesterol-lowering treatments like statins, a new oral medication, enlicitide, is showing promise as an easier-to-use alternative for reducing the risk of heart disease and stroke.
Heart disease remains the leading cause of death in the United States, and high LDL cholesterol – contributing to plaque buildup in arteries – is a significant factor. This new research, published in the New England Journal of Medicine, offers a potential breakthrough for millions.
The Challenge with Current Treatments
Currently, patients needing more aggressive cholesterol reduction often rely on injectable PCSK9 inhibitors, which can be expensive and inconvenient.
The study involved over 2,909 high-risk participants who were assigned either a daily enlicitide pill or a placebo, in addition to their standard treatment. Dr. Ann Marie Navar, a cardiologist at UT Southwestern Medical Center and the study’s lead author, noted that even high-intensity statins often fail to achieve optimal cholesterol levels for many patients.
Participants taking enlicitide experienced a cholesterol reduction of up to 60 percent over six months.
According to Dr. Navar, “none come close to the degree of LDL cholesterol lowering that we see with enlicitide.”
Looking Ahead: FDA Approval and Further Research
Merck, the company funding the study, is seeking FDA approval for enlicitide and has requested an ultra-prompt review process.
However, it’s important to note that the current study doesn’t yet demonstrate whether this cholesterol reduction translates directly into lower risks of heart attacks or strokes. Merck is conducting a larger study with over 14,000 participants to gather this crucial data.
While enlicitide isn’t yet available, it represents a promising step toward a more effective and accessible treatment for high cholesterol. Maintaining a healthy lifestyle – including a balanced diet, regular exercise, and routine medical checkups – remains the cornerstone of preventative heart health.
YOU MIGHT ALSO LIKE:
Wearables are Watching Over Your Wellness
New Stethoscope Could Diagnose Heart Conditions in 15 Seconds
New AI Technology Helps Hospitals Treat Stroke Patients Faster and Better
Bonnie has dedicated her life to promoting social justice. She loves to write about empowering women, helping children, educational innovations, and advocating for the environment & sustainability.
Frequently Asked Questions
- What is enlicitide? Enlicitide is an experimental oral medication designed to lower LDL cholesterol levels.
- How much did cholesterol levels drop in the study? Participants taking enlicitide experienced a cholesterol reduction of up to 60 percent over six months.
- Is enlicitide currently available? No, enlicitide is still under review by the FDA.
- What is PCSK9? PCSK9 is a protein that prevents the liver from removing LDL cholesterol from the blood. Inhibiting PCSK9 can lower cholesterol levels.
